Where does NeOnc Technologies, Inc. rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), NeOnc Technologies, Inc. ranks #12,584 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does NeOnc Technologies, Inc. hold?

NeOnc Technologies, Inc. holds 24 US utility patents granted between 2015 and 2023, spanning 7 technology areas.

What is NeOnc Technologies, Inc.'s Innovation Score?

NeOnc Technologies, Inc. has an Innovation Score of 28.2 out of 100 (26th percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does NeOnc Technologies, Inc. focus on?

NeOnc Technologies, Inc.'s top technology area is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations) with 22 patents, ranking #884 of 6,058 assignees active in that subclass. Grants appear in 7 CPC subclasses total.

Is NeOnc Technologies, Inc.'s patent grant rate increasing or decreasing?

NeOnc Technologies, Inc.'s recent grant velocity is -50% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for NeOnc Technologies, Inc.'s patents?

NeOnc Technologies, Inc.'s patents average 9.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the NeOnc Technologies, Inc. patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView US Corporation

NeOnc Technologies, Inc.

USPTO PatentsView assignee record - 24 granted patents across 7 technology areas, recorded in grant years 2015–2023. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, Neonc ranks #12,584 of 49,997 tracked US assignees by granted-patent volume, with 24 patents across 7 technology areas.

#12,584
of 49,997 US assignees by volume: 26th percentile
by Innovation Score (28.2/100): 9.8
avg claims per patent: -50%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R12584 · US Corporation #12,584 · 24 grants

GRANTS-SMALL · MID-PACK · PHOTO-FINISH · CPC-NARROW · INNOV-THIN · CLAIMS-PAR · TYPE-USCORP · VEL-DROP · BOOK-FULL

GRANTS-SMALL 24 grants
MID-PACK #12,584/49,997
PHOTO-FINISH Nanchang Coolpad…
CPC-NARROW A61P · 7 areas
INNOV-THIN 28.2/100
CLAIMS-PAR 9.8 claims/avg
TYPE-USCORP US Corporation
VEL-DROP -50% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Nanchang Coolpad Intelligent Technology Company Limited (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Neonc’s 28.2 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Volume 11.1 pts (39%) Velocity 1.9 pts (7%) Breadth 9.4 pts (33%) Claim depth 5.9 pts (21%)

Qualcomm Incorporated · highest

85
NeOnc · this assignee

28
3D Lighting… · lowest

7

What this shows Neonc's Innovation Score is 28.2/100 (26th percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Does more volume mean deeper claims for Neonc?

Each dot is one of Neonc’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Neonc’s own 9.8 claims/patent is at or below the 13.6 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Neonc vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Neonc's grants concentrate

NeOnc Technologies, Inc. is a focused PatentsView assignee: 7 CPC subclasses with 91.7% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2017 (5 grants) versus a trough of 1 in 2019. By volume, Neonc sits between Nanchang Coolpad Intelligent Technology Company Limited and Ningbo SKL International Co., Ltd..

Neonc's three-year grant acceleration

NeOnc Technologies, Inc. shows 2 grants in 2022–2024 against only 7 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Nanchang Coolpad…

24
Nanchang Hangkong…

24
Natus Medical Inc…

24
Navitar Industries

24
Nemak B de C V

24
Nemo Equipment

24
Nepes

24
Ningbo SKL Intern…

24
Neonc ◀

24

What this shows NeOnc holds 24 patents at rank #12,593, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near NeOnc

By rank, the assignees closest to #12,593 in granted patent volume.

Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)

Other assignees with the most granted patents in NeOnc's primary technology class.

Neonc's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

28 26th percentile higher than 26% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2023

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

NeOnc Technologies, Inc. patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	8.3%
2016	4	16.7%
2017	5	20.8%
2018	4	16.7%
2019	1	4.2%
2020	2	8.3%
2021	4	16.7%
2022	1	4.2%
2023	1	4.2%

Which technologies does NeOnc Technologies, Inc. patent most?

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 22

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 19

A61N - ELECTROTHERAPY; MAGNETOTHERAPY; Radiation THERAPY; Ultrasound Therapy 15

C07C - Acyclic OR Carbocyclic Compounds 15

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 14

C07D - Heterocyclic Compounds 14

A61M - Devices FOR Introducing Media Into, OR Onto, THE Body ; Devices FOR Transducing Body Media OR FOR Taking Media From THE Body ; Devices FOR Producing OR Ending Sleep OR Stupor 1

Top 7 of 7 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

View all rankings → How is Innovation Score calculated?

What to do with this data

NeOnc Technologies, Inc.'s patent record in context - here's where to go next.

NeOnc Technologies, Inc.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 91.7% of its portfolio - see every assignee active in that class. Explore A61P
Ranked #12,584 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare NeOnc Technologies, Inc. against Nanchang Coolpad Intelligent Technology Company Limited, an assignee filing at a similar volume. Compare portfolios
Innovation Score of 28.2/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.